Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA ...

Patients with lung adenocarcinoma – the most common type of cancer among non-smokers -- carry a specific mutation in the ...

In the continuing evolution of personalized medicine, a new study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with ...

Patients with lung adenocarcinoma typically carry a mutation in the Epidermal Growth Factor Receptor (EGFR) gene, making them ...

A new study has found that lung cancer tumors 'feed' off sugar and shed light on the link between diet and the disease.

After being used since the 1940s in various industries, asbestos is now linked to severe health risks, including asbestosis, ...

With symptoms that often mimic other respiratory conditions, ILD is frequently misdiagnosed or unrecognized. However, in the Philippines, hope is in the horizon.

Qure.ai, a global leader in artificial intelligence (AI) for healthcare, today announced the launch of India’s first AI-led ...

NEIGHBOURS veteran Ian Smith has given an update on his health after being diagnosed with terminal cancer in December. The ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

Advancing pipeline of inhaled treprostinil products in clinical studies Strengthened financial position by up to $100 million via amendment to existing financing agreement with HealthCare Royalty ...

Net research and development expenses for the device division increased in 2024 to CAD175,000 from CAD44,000 in 2023, a 400% increase. The increase is attributed to development of a new software ...